A new study from the University of Pittsburgh Center for Vaccine Research published today in the Journal of Experimental Medicine describes a previously unappreciated role for a class of immune cells in the early stages of tuberculosis (TB) infection.
Samsung Biologics touts Q2 performance after expanding deals with big pharmas
CDMO Samsung Biologics said its revenue jumped 33% in the second quarter, during which it announced deals with major drugmakers like Pfizer and Novartis The